Platelet collagen receptors, signaling and antagonism: Emerging approaches for the prevention of intravascular thrombosis

Thrombosis Research

Volumn 122, Issue 6, 2008, Pages 786-803

  Surin, William Rasican ^a   Barthwal, Manoj Kumar ^a   Dikshit, Madhu ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Collagen antagonist; Collagen receptor; Platelet signaling; Polymorphism; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ACURHAGIN; AGGRETIN; AGKICETIN C; ALBOAGGREGIN A; ALPHA2 INTEGRIN; ASPARTYLGLYCYLGLUTAMYLALANINE; CAFFEIC ACID PHENETHYL ESTER; CATROCOLLASTATIN; CD36 ANTIGEN; CLOPIDOGREL; CONVULXIN; CROVIDISIN; D 003; FRANGULIN; GLYCOPROTEIN IIB; GLYCOPROTEIN VI; GLYCYLPROLYLHYDROXYPROLINE; JAQ1; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCLONAL ANTIBODY; OPHIOLUXIN; POLYCLONAL ANTIBODY; PROTEIN INHIBITOR; PSI 697; QUERCETIN; RHAMNUS EXTRACT; SNAKE VENOM; SYNTHETIC PEPTIDE; TRIMUCYTIN; UNCLASSIFIED DRUG;

ALLELE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIUM INJURY; ENZYME ACTIVATION; GENOTYPE; HAPLOTYPE; HEART MUSCLE ISCHEMIA; HUMAN; LIGAND BINDING; NONHUMAN; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMORPHISM; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VEIN THROMBOSIS;

ANIMALS; CALCIUM; COLLAGEN; HUMANS; INTEGRIN ALPHA2; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC; RECEPTORS, COLLAGEN; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 52049111404     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.10.005     Document Type: Review

References (211)

1. Farndale R.W. Collagen-induced platelet activation. Blood Cells Mol Dis 36 (2006) 162-165
2. Plenz G.A., Deng M.C., Robenek H., and Volker W. Vascular collagens: spotlight on the role of type VIII collagen in atherogenesis. Atherosclerosis 166 (2003) 1-11
3. Farndale R.W., Sixma J.J., Barnes M.J., and de Groot P.G. The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2 (2004) 561-573
4. Saelman E.U., Horton L.F., Barnes M.J., Gralnick H.R., Hese K.M., Nieuwenhuis H.K., et al. Platelet adhesion to cyanogen-bromide fragments of collagen α1(I) under flow conditions. Blood 82 (1993) 3029-3033
5. Murata K., Motayama T., and Kotake C. Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis 60 (1986) 251-262
6. 1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood 106 (2005) 1268-1277
7. Jackson S.P., Nesbitt W.S., and Kulkarni S. Signaling events underlying thrombus formation. J Thromb Haemost 1 (2003) 1602-1612
8. Massberg S., Gawaz M., Grüner S., Schulte V., Konrad I., Zohlnhöfer D., et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 197 (2003) 41-49
9. Bultmann A., Herdeg C., Li Z., Munch G., Baumgartner C., Langer H., et al. Local delivery of soluble platelet collagen receptor glycoprotein VI inhibits thrombus formation in vivo. Thromb Haemost 95 (2006) 763-766
10. Vanhoorelbeke K., Ulrichts H., Schoolmeester A., and Deckmyn H. Inhibition of platelet adhesion to collagen as a new target for antithrombotic drugs. Curr Drug Targets Cardiovasc Haematol Disord 3 (2003) 125-140
11. Kahn M.L. Platelet-collagen responses: molecular basis and therapeutic promise. Semin Thromb Hemost 30 (2004) 419-425
12. Siljander P.R., Munnix I.C., Smethurst P.A., Deckmyn H., Lindhout T., Ouwehand W.H., et al. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 103 (2004) 1333-1341
13. Steinhubl S.R., and Moliterno D.J. The role of the platelet in the pathogenesis of atherothrombosis. Am J Cardiovasc Drugs 5 (2005) 399-408
14. Badimon L., Badimon J.J., Turitto V.T., Vallabhajosula S., and Fuster V. Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation. Circulation 78 (1988) 1431-1442
15. Bernardo A., Bergeron A.L., Sun C.W., Guchhait P., Cruz M.A., López J.A., et al. von Willebrand factor present in fibrillar collagen enhances platelet adhesion to collagen and collagen-induced platelet aggregation. J Thromb Haemost 2 (2004) 660-669
16. Bennett J.S. Structural biology of glycoprotein IIb-IIIa. Trends Cardiovasc Med 6 (1996) 31-37
17. Yip J., Shen Y., Berndt M.C., and Andrews R.K. Primary platelet adhesion receptors. IUBMB Life 57 (2005) 103-108
18. Savage B., Saldivar E., and Ruggeri Z.M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84 (1996) 289-297
19. Savage B., Almus-Jacobs F., and Ruggeri Z.M. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 94 (1998) 657-666
20. Tomokiyo K., Kamikubo Y., Hanada T., Araki T., Nakatomi Y., Ogata Y., et al. von Willebrand factor accelerates platelet adhesion and thrombus formation on a collagen surface in platelet-reduced blood under flow conditions. Blood 105 (2005) 1078-1084
21. Reininger A.J., Heijnen H.F., Schumann H., Specht H.M., Schramm W., and Ruggeri Z.M. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 107 (2006) 3537-3545
22. Chow T.W., Hellums J.D., Moake J.L., and Kroll M.H. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood 80 (1992) 113-120
23. Barnes M.J., Knight C.G., and Farndale R.W. The collagen-platelet interaction. Curr Opin Hematol 5 (1998) 314-320
24. Sixma J.J., van Zanten G.H., Huizinga E.G., van der Plas R.M., Verkley M., Wu Y.P., et al. Platelet adhesion to collagen: an update. Thromb Haemost 78 (1997) 434-438
25. Chen H., and Kahn M.L. Reciprocal signaling by integrin and nonintegrin receptors during collagen activation of platelets. Mol Cell Biol 23 (2003) 4764-4777
26. Konstantinides S., Ware J., Marchese P., Almus-Jacobs F., Loskutoff D.J., and Ruggeri Z.M. Distinct antithrombotic consequences of platelet glycoprotein Ib alpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost 4 (2006) 2014-2021
27. Andrews R.K., Gardiner E.E., Shen Y., and Berndt M.C. Platelet interactions in thrombosis. IUBMB Life 56 (2004) 13-18
28. 3 signaling in platelets. Blood 93 (1999) 2645-2652
29. Atkinson B.T., Stafford M.J., Pears C.J., and Watson S.P. Signalling events underlying platelet aggregation induced by the glycoprotein VI agonist convulxin. Eur J Biochem 268 (2001) 5242-5248
30. Asselin J., Gibbins J.M., Achison M., Lee Y.H., Morton L.F., Farndale R.W., et al. A collagen-like peptide stimulates tyrosine phosphorylation of Syk and phospholipase C γ2 in platelets independent of the integrin alpha2beta1. Blood 89 (1997) 1235-1242
31. Faili A., Randon J., Francischetti I.M., Vargaftig B.B., and Hatmi M. Convulxin-induced platelet aggregation is accompanied by a powerful activation of the phospholipase C pathway. Biochem J 298 (1994) 87-91
32. Batra S., Roy A.K., Patra A., Bhaduri A.P., Surin W.R., Raghavan S.A., et al. Baylis-Hillman reaction assisted parallel synthesis of 3,5-disubstituted isoxazoles and their in vivo bioevaluation as antithrombotic agents. Bioorg Med Chem 12 (2004) 2059-2077
33. Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 138 (2001) 152-163
34. Qu C., Wang J., Wan W., Li C., and Wu S. Establishment of a flow cytometric assay for determination of human platelet glycoprotein VI based on a mouse polyclonal antibody. J Clin Lab Anal 20 (2006) 250-254
35. Kao S., Turner N.A., Moake J.L., and McIntire L.V. A novel flow cytometric analysis for platelet activation on immobilized von Willebrand factor or fibrillar collagen. J Thromb Haemost 1 (2003) 347-354
36. Cosemans J.M., Kuijpers M.J., Lecut C., Loubele S.T., Heeneman S., Jandrot-Perrus M., et al. Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions. Atherosclerosis 181 (2005) 19-27
37. Hemker H.C., Giesen P.L., Ramjee M., Wagenvoord R., and Beguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 83 (2000) 589-591
38. Herault J.P., Dol F., Gaich C., Bernat A., and Herbert J.M. Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat. Thromb Haemost 81 (1999) 957-960
39. Wee J.L., and Jackson D.E. Phosphotyrosine signaling in platelets: lessons for vascular thrombosis. Curr Drug Targets 7 (2006) 1265-1273
40. Rosado J.A., Nunez A.M., Pariente J.A., and Salido G.M. Alterations in intracellular calcium homeostasis and platelet aggregation induced by ethanol. Biochem Biophys Res Commun 341 (2006) 917-924
41. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260 (1985) 3440-3450
42. Riba R., Sharifi M., Farndale R.W., and Naseem K.M. Regulation of platelet guanylyl cyclase by collagen: evidence that Glycoprotein VI mediates platelet nitric oxide synthesis in response to collagen. Thromb Haemost 94 (2005) 395-403
43. Li Z., Xi X., Gu M., Feil R., Ye R.D., Eigenthaler M., et al. A stimulatory role for cGMP-dependent protein kinase in platelet activation. Cell 112 (2003) 77-86
44. Marcondes S., Cardoso M.H., Morganti R.P., Thomazzi S.M., Lilla S., Murad F., et al. Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration. Proc Natl Acad Sci 103 (2006) 3434-3439
45. DiMinno G., and Silver M.J. Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. J Pharmacol Exp Ther 225 (1983) 57-60
46. Matsuno H., Kozawa O., Niwa M., and Uematsu T. Inhibition of von Willebrand factor binding to platelet GP Ib by a fractionated aurintricarboxylic acid prevents restenosis after vascular injury in hamster carotid artery. Circulation 96 (1997) 1299-1304
47. Andre P., Hainaud P., Bal dit Sollier C., Garfinkel L.I., Caen J.P., and Drouet L.O. Relative involvement of GPIb/IX-vWF axis and GPIIb/IIIa in thrombus growth at high shear rates in the guinea pig. Arterioscler Thromb Vasc Biol 17 (1997) 919-924
48. Kurz K.D., Main B.W., and Sandusky G.E. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 60 (1990) 269-280
49. Furie B.C., and Furie B. Tissue factor pathway vs. collagen pathway for in vivo platelet activation. Blood Cells Mol Dis 36 (2006) 135-138
50. Nieswandt B., Aktas B., Moers A., and Sachs U.J.H. Platelets in atherothrombosis: lessons from mouse models. J Thromb Haemost 3 (2005) 1725-1736
51. Dejana E., Callioni A., Quintana A., and Gaetano G. Bleeding time in laboratory animals. II - a comparison of different assay conditions in rats. Thromb Res 15 (1979) 191-197
52. Heino J. The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix Biol 19 (2000) 319-323
53. Santoro S.A., Rajpara S.M., Staatz W.D., and Woods Jr. V.L. Isolation and characterization of a platelet surface collagen-binding complex related to VLA-2. Biochem Biophys Res Commun 153 (1988) 217-223
54. Santoro S.A. Identification of a 160,000 Da platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 46 (1986) 913-920
55. 1 density and von Willebrand factor. Blood 96 (2000) 1433-1437
56. Nieuwenhuis H.K., Akkerman J.W., Houdijk W.P., and Sixma J.J. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318 (1985) 470-472
57. Kehrel B., Balleisen L., Kokott R., Mesters R., Stenzinger W., Clemetson K.J., et al. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 71 (1988) 1074-1078
58. 1 activity on human platelets. Blood 82 (1993) 2693-2703
59. 1 might be a genetic risk factor for the development of stroke in younger patients. Blood 93 (1999) 3583-3586
60. Moshfegh K., Wuillemin W.A., Redondo M., Lammle B., Beer J.H., Liechti-Gallati S., et al. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 353 (1999) 351-354
61. 1 and prior myocardial infarction in human subjects, a pilot study. Med Sci Monit 11 (2005) CR224-CR229
62. 1 integrin and development of atherosclerosis in a mouse model: assessment of risk. Arterioscler Thromb Vasc Biol 23 (2003) 2104-2109
63. Chiang T.M., Takayama H., and Postlethwaite A.E. Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis. Thromb Res 117 (2006) 299-306
64. Ichinohe T., Takayama H., Ezumi Y., Arai M., Yamamoto N., Takahashi H., et al. Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI. J Biol Chem 272 (1997) 63-68
65. Kehrel B., Wierwille S., Clemetson K.J., Anders O., Steiner M., Knight C.G., et al. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood 91 (1998) 491-499
66. 1 integrin and GP VI. J Biol Chem 274 (1999) 11897-11903
67. Siljander P., and Lassila R. Studies of adhesion-dependent platelet activation: distinct roles for different participating receptors can be dissociated by proteolysis of collagen. Arterioscler Thromb Vasc Biol 19 (1999) 3033-3043
68. Suzuki-Inoue K., Yatomi Y., Asazuma N., Kainoh M., Tanaka T., Satoh K., et al. Rac, a small guanosine triphosphate-binding protein, and p21-activated kinase are activated during platelet spreading on collagen-coated surfaces: roles of integrin alpha(2)beta(1). Blood 98 (2001) 3708-3716
69. He L., Pappan L.K., Grenache D.G., Li Z., Tollefsen D.M., Santoro S.A., et al. The contributions of the alpha 2 beta 1 integrin to vascular thrombosis in vivo. Blood 102 (2003) 3652-3657
70. Atkinson B.T., Jarvis G.E., and Watson S.P. Activation of GPVI by collagen is regulated by alpha2beta1 and secondary mediators. J Thromb Haemost 1 (2003) 1278-1287
71. Chen H., Locke D., Liu Y., Liu C., and Kahn M.L. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J Biol Chem 277 (2002) 3011-3019
72. Nieswandt B., Brakebusch C., Bergmeier W., Schulte V., Bouvard D., Mokhtari-Nejad R., et al. Glycoprotein VI but not a2b1 integrin is essential for platelet interaction with collagen. EMBO J 20 (2001) 2120-2130
73. Nieswandt B., Schulte V., Bergmeier W., Mokhtari-Nejad R., Rackebrandt K., Cazenave J.P., et al. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med 193 (2001) 459-469
74. Holtkotter O., Nieswandt B., Smyth N., Muller W., Hafner M., Schulte V., et al. Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem 277 (2002) 10789-10794
75. Jung S.M., and Moroi M. Activation of the platelet collagen receptor integrin alpha (2) beta (1): its mechanism and participation in the physiological functions of platelets. Trends Cardiovasc Med 10 (2000) 285-292
76. Jung S.M., and Moroi M. Signal-transducing mechanisms involved in activation of the platelet collagen receptor integrin alpha (2) beta (1). J Biol Chem 275 (2000) 8016-8026
77. Watson S., Berlanga O., Best D., and Frampton J. Update on collagen receptor interactions in platelets: is the two-state model still valid?. Platelets 11 (2000) 252-258
78. Nieswandt B., Bergmeier W., Eckly A., Schulte V., Ohlmann P., Cazenave J.P., et al. Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation. Blood 97 (2001) 3829-3835
79. Inoue O., Suzuki-Inoue K., Dean W.L., Frampton J., and Watson S.P. Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. J Cell Biol 160 (2003) 769-780
80. Briddon S.J., Melford S.K., Turner M., Tybulewicz V., and Watson S.P. Collagen mediates changes in intracellular calcium in primary mouse megakaryocytes through Syk-dependent and -independent pathways. Blood 93 (1999) 3847-3855
81. Achison M., Elton C.M., Hargreaves P.G., Knight C.G., Barnes M.J., and Farndale R.W. Integrin-independent tyrosine phosphorylation of p125 (Fak) in human platelets stimulated by collagen. J Biol Chem 276 (2001) 3167-3174
82. Polanowska-Grabowska R., Geanacopoulos M., and Gear A.R. Platelet adhesion to collagen via the alpha 2 beta 1 integrin under arterial flow conditions causes rapid tyrosine phosphorylation of pp125FAK. Biochem J 296 (1993) 543-547
83. Gear A.R., Simon C.G., and Polanowska-Grabowska R. Platelet adhesion to collagen activates a phosphoprotein complex of heat-shock proteins and protein phosphatase1. J Neural Transm 104 (1997) 1037-1047
84. Gao J., Zoller K.E., Ginsberg M.H., Brugge J.S., and Shattil S.J. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3. EMBO J 16 (1997) 6414-6425
85. Obergfell A., Judd B.A., del Pozo M.A., Schwartz M.A., Koretzky G.A., and Shattil S.J. The molecular adapter SLP-76 relays signals from platelet integrin alphaIIbbeta3 to the actin cytoskeleton. J Biol Chem 276 (2001) 5916-5923
86. Bernardi B., Guidetti G.F., Campus F., Crittenden J.R., Graybiel A.M., Balduini C., et al. The small GTPase Rap1b regulates the cross talk between platelet integrin alpha2beta1 and integrin alphaIIbbeta3. Blood 107 (2006) 2728-2735
87. Nadal F., Levy-Toledano S., Grelac F., Caen J.P., Rosa J.P., and Bryckaert M. Negative regulation of mitogen-activated protein kinase activation by integrin alphaIIbbeta3 in platelets. J Biol Chem 272 (1997) 22381-22384
88. Bugaud F., Nadal-Wollbold F., Levy-Toledano S., Rosa J.P., and Bryckaert M. Regulation of c-jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood 94 (1999) 3800-3805
89. Canobbio I., Balduini C., and Torti M. Signalling through the platelet glycoprotein Ib-V-IX complex. Cell Signal 16 (2004) 1329-1344
90. Saklatvala J., Rawlinson L., Waller R.J., Sarsfield S., Lee J.C., Morton L.F., et al. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem 271 (1996) 6586-6589
91. Siljander P., Farndale R.W., Feijge M.A., Comfurius P., Kos S., Bevers E.M., et al. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: involvement of p38 MAP kinase and calpain. Arterioscler Thromb Vasc Biol 21 (2001) 618-627
92. Oury C., Kuijpers M.J., Toth-Zsamboki E., Bonnefoy A., Danloy S., Vreys I., et al. Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood 101 (2003) 3969-3976
93. Nieswandt B., and Watson S.P. Platelet-collagen interaction: is GPVI the central receptor?. Blood 102 (2003) 449-461
94. Moroi M., and Jung S.M. Platelet glycoprotein VI: its structure and function. Thromb Res 114 (2004) 221-233
95. Miura Y., Takahashi T., Jung S.M., and Moroi M. Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen. A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen. J Biol Chem 277 (2002) 46197-46204
96. Smethurst P.A., Joutsi-Korhonen L., O'Connor M.N., Wilson E., Jennings N.S., Garner S.F., et al. Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody. Blood 103 (2004) 903-911
97. Kato K., Kanaji T., Russell S., Kunicki T.J., Furihata K., Kanaji S., et al. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 102 (2003) 1701-1707
98. Gruner S., Prostredna M., Koch M., Miura Y., Schulte V., Jung S.M., et al. Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice. Blood 105 (2005) 1492-1499
99. Polgar J., Clemetson J.M., Kehrel B.E., Wiedemann M., Magnenat E.M., Wells T.N., et al. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem 272 (1997) 13576-13583
100. 1. J Biol Chem 272 (1997) 27035-27041
101. Sugiyama T., Okuma M., Ushikubi F., Sensaki S., Kanaji K., and Uchino H. A novel platelet-aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 69 (1987) 1712-1720
102. Moroi M., Jung S.M., Okuma M., and Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 84 (1989) 1440-1445
103. Watson S.P., Asazuma N., Atkinson B., Berlanga O., Best D., Bobe R., et al. The role of ITAM- and ITIM-coupled receptors in platelet activation by collagen. Thromb Haemost 86 (2001) 276-288
104. Gardiner E.E., Arthur J.F., Kahn M.L., Berndt M.C., and Andrews R.K. Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood 104 (2004) 3611-3617
105. Stephens G., Yan Y., Jandrot-Perrus M., Villeval J.L., Clemetson K.J., and Phillips D.R. Platelet activation induces metalloproteinase-dependent GPVI cleavage to down-regulate platelet reactivity to collagen. Blood 105 (2005) 186-191
106. Schulte V., Rabie T., Prostredna M., Aktas B., Gruner S., and Nieswandt B. Targeting of the collagen-binding site on glycoprotein VI is not essential for in vivo depletion of the receptor. Blood 101 (2003) 3948-3952
107. Tsuji M., Ezumi Y., Arai M., and Takayama H. A novel association of Fc receptor c-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets. J Biol Chem 272 (1997) 23528-23531
108. Zheng Y.M., Liu C., Chen H., Locke D., Ryan J.C., and Kahn M.L. Expression of the platelet receptor GPVI confers signaling via the Fc receptor gamma -chain in response to the snake venom convulxin but not to collagen. J Biol Chem 276 (2001) 12999-13006
109. Gibbins J., Asselin J., Farndale R., Barnes M.J., Law C.L., and Watson S.P. Tyrosine phosphorylation of the Fc receptor c-chain in collagen stimulated platelets. J Biol Chem 271 (1996) 18095-18099
110. Bori-Sanz T., Inoue K.S., Berndt M.C., Watson S.P., and Tulasne D. Delineation of the region in the glycoprotein VI tail required for association with the Fc receptor gamma-chain. J Biol Chem 278 (2003) 35914-35922
111. Nieswandt B., Bergmeier W., Schulte V., Rackebrandt K., Gessner J.E., and Zirngibl H. Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcR γ-chain. J Biol Chem 275 (2000) 23998-24002
112. Poole A., Gibbins J.M., Turner M., van Vugt M.J., van de Winkel J.G., Saito T., et al. The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 16 (1997) 2333-2341
113. 1 in platelet shape change and aggregation induced by different collagens. Br J Pharmacol 137 (2002) 107-117
114. Konishi H., Katoh Y., Takaya N., Kashiwakura Y., Itoh S., Ra C., et al. Platelets activated by collagen through immunoreceptor tyrosine-based activation motif play pivotal role in initiation and generation of neointimal hyperplasia after vascular injury. Circulation 105 (2002) 912-916
115. Dubois C., Panicot-Dubois L., Merrill-Skoloff G., Furie B., and Furie B.C. Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood 107 (2006) 3902-3906
116. Andrews R.K., Suzuki-Inoue K., Shen Y., Tulasne D., Watson M.C., and Berndt M.C. Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI. Blood 99 (2002) 4219-4221
117. Chen H., Locke D., Liu Y., Liu C., and Kahn M.L. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J Biol Chem 277 (2002) 3011-3019
118. Bigalke B., Lindemann S., Ehlers R., Seizer P., Daub K., Langer H., et al. Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome. Eur Heart J 27 (2006) 2165-2169
119. Suzuki-Inoue K., Tulasne D., Shen Y., Bori-Sanz T., Inoue O., Jung S.M., et al. Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling. J Biol Chem 277 (2002) 21561-21566
120. Locke D., Liu C., Peng X., Chen H., and Kahn M.L. Fc Rγ in dependent signaling by the platelet collagen receptor glycoprotein VI. J Biol Chem 278 (2003) 15441-15448
121. Gross B.S., Lee J.R., Clements J.L., Turner M., Tybulewicz V.L., Findell P.R., et al. Tyrosine phosphorylation of SLP-76 is downstream of Syk following stimulation of the collagen receptor in platelets. J Biol Chem 274 (1999) 5963-5971
122. Clements J.L., Lee J.R., Gross B., Yang B., Olson J.D., Sandra A., et al. Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice. J Clin Invest 103 (1999) 19-25
123. Pasquet J.M., Gross B., Quek L., Asazuma N., Zhang W., Sommers C.L., et al. LAT is required for tyrosine phosphorylation of phospholipase Cγ2 and platelet activation by the collagen receptor GPVI. Mol Cell Biol 19 (1999) 8326-8334
124. Nonne C., Lenain N., Hechler B., Mangin P., Cazenave J.P., Gachet C., et al. Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity. Arterioscler Thromb Vasc Biol 25 (2005) 1293-1298
125. Munnix I.C., Strehl A., Kuijpers M.J., Auger J.M., van der Meijden P.E., van Zandvoort M.A., et al. The glycoprotein VI-phospholipase Cgamma2 signaling pathway controls thrombus formation induced by collagen and tissue factor in vitro and in vivo. Arterioscler Thromb Vasc Biol 25 (2005) 2673-2678
126. Quek L.S., Pasquet J.M., Hers I., Cornall R., Knight G., Barnes M., et al. Fyn and Lyn phosphorylate the Fc receptor γ chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway. Blood 96 (2000) 4246-4253
127. Vidal C., Geny B., Melle J., Jandrot-Perrus M., and Fontenay-Roupie M. Cdc42/Rac1-dependent activation of the p21-activated kinase (PAK) regulates human platelet lamellipodia spreading: implication of the cortical-actin binding protein cortactin. Blood 100 (2002) 4462-4469
128. Yang S.A., Carpenter C.L., and Abrams C.S. Rho and Rho-kinase mediate thrombin-induced phosphatidylinositol 4-phosphate 5-kinase trafficking in platelets. J Biol Chem 279 (2004) 42331-42336
129. Suzuki-Inoue K., Yatomi Y., Asazuma N., Kainoh M., Tanaka T., Satoh K., et al. Rac, a small guanosine triphosphate-binding protein, and p21-activated kinase are activated during platelet spreading on collagen-coated surfaces: roles of integrin α2β1. Blood 98 (2001) 3708-3716
130. Soulet C., Gendreau S., Missy K., Benard V., Plantavid M., and Payrastre B. Characterisation of Rac activation in thrombin- and collagen-stimulated human Blood platelets. FEBS Lett 507 (2001) 253-258
131. Choi W., Karim Z.A., and Whiteheart S.W. Arf6 plays an early role in platelet activation by collagen and convulxin. Blood 107 (2006) 3145-3152
132. Larson M.K., Chen H., Kahn M.L., Taylor A.M., Fabre J.E., Mortensen R.M., et al. Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets. Blood 101 (2003) 1409-1415
133. Jung S.M., Ohnuma M., Watanabe N., Sonoda M., Handa M., and Moroi M. Analyzing the mechanism of Rap1 activation in platelets: Rap1 activation is related to the release reaction mediated through the collagen receptor GPVI. Thromb Res 118 (2006) 509-521
134. Pearce A.C., Senis Y.A., Billadeau D.D., Turner M., Watson S.P., and Vigorito E. Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen. J Biol Chem 279 (2004) 53955-53962
135. 1 integrin, GPVI, and Src tyrosine kinases. Arterioscler Thromb Vasc Biol 23 (2003) 1934-1940
136. Gibbins J.M., Briddon S., Shutes A., van Vugt M.J., van de Winkel J.G., Saito T., et al. The p85 subunit of phosphatidylinositol 3-kinase associates with the Fc receptor γ-chain and linker for activator of T cells (LAT) in platelets stimulated by collagen and convulxin. J Biol Chem 273 (1998) 34437-34443
137. Hirsch E., Bosco O., Tropel P., Laffargue M., Calvez R., Altruda F., et al. Resistance to thromboembolism in PI3Kgamma-deficient mice. FASEB J 15 (2001) 2019-2021
138. Watanabe N., Nakajima H., Suzuki H., Oda A., Matsubara Y., Moroi M., et al. Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation. Blood 102 (2003) 541-548
139. Yi Q., Suzuki-Inoue K., Asazuma N., Inoue O., Watson S.P., and Ozaki Y. Docking protein Gab2 positively regulates glycoprotein VI-mediated platelet activation. Biochem Biophys Res Commun 337 (2005) 446-451
140. Senis Y.A., Sangrar W., Zirngibl R.A., Craig A.W., Lee D.H., and Greer P.A. Fps/Fes and Fer non-receptor protein-tyrosine kinases regulate collagen- and ADP-induced platelet aggregation. J Thromb Haemost 1 (2003) 1062-1070
141. Borsch-Haubold A.G., Ghomashchi F., Pasquet S., Goedert M., Cohen P., Gelb M.H., et al. Phosphorylation of cytosolic phospholipase A2 in platelets is mediated by multiple stress-activated protein kinase pathways. Eur J Biochem 265 (1999) 195-203
142. Gross B.S., Wilde J.I., Quek L., Chapel H., Nelson D.L., and Watson S.P. Regulation and function of WASp in platelets by the collagen receptor, glycoprotein VI. Blood 94 (1999) 4166-4176
143. Oda A., Ikeda Y., Ochs H.D., Druker B.J., Ozaki K., Handa M., et al. Rapid tyrosine phosphorylation and activation of Bruton's tyrosine/Tec kinases in platelets induced by collagen binding or CD32 cross-linking. Blood 95 (2000) 1663-1670
144. Pasquet J.M., Quek L., Stevens C., Bobe R., Huber M., Duronio V., et al. Phosphatidylinositol 3,4,5-trisphosphate regulates Ca(2+) entry via btk in platelets and megakaryocytes without increasing phospholipase C activity. EMBO J 19 (2000) 2793-2802
145. Bobe R., Wilde J.I., Maschberger P., Venkateswarlu K., Cullen P.J., Siess W., et al. Phosphatidylinositol 3-kinase-dependent translocation of phospholipase Cgamma2 in mouse megakaryocytes is independent of Bruton tyrosine kinase translocation. Blood 97 (2001) 678-684
146. Lecut C., Feijge M.A., Cosemans J.M., Jandrot-Perrus M., and Heemskerk J.W. Fibrillar type I collagens enhance platelet-dependent thrombin generation via glycoprotein VI with direct support of alpha2beta1 but not alphaIIbbeta3 integrin. Thromb Haemost 94 (2005) 107-114
147. Keuren J.F., Wielders S.J., Ulrichts H., Hackeng T., Heemskerk J.W., Deckmyn H., et al. Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1. Arterioscler Thromb Vasc Biol 25 (2005) 1499-1505
148. Mangin P., Yap C.L., Nonne C., Sturgeon S.A., Goncalves I., Yuan Y., et al. Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRgamma deficiency. Blood 107 (2006) 4346-4353
149. Cho J., and Mosher D.F. Role of fibronectin assembly in platelet thrombus formation. J Thromb Haemost 4 (2006) 1461-1469
150. Leng X.H., Zhang W., Nieswandt B., and Bray P.F. Effects of estrogen replacement therapies on mouse platelet function and glycoprotein VI levels. Circ Res 97 (2005) 415-417
151. Fung C.Y., Brearley C.A., Farndale R.W., and Mahaut-Smith M.P. A major role for P2X1 receptors in the early collagen-evoked intracellular Ca2+ responses of human platelets. Thromb Haemost 94 (2005) 37-40
152. Begonja A.J., Gambaryan S., Geiger J., Aktas B., Pozgajova M., Nieswandt B., et al. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway. Blood 106 (2005) 2757-2760
153. Antl M., von Bruhl M.L., Eiglsperger C., Werner M., Konrad I., Kocher T., et al. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood 109 (2007) 552-559
154. Clemetson K.J., and Clemetson J.M. Platelet collagen receptors. Thromb Haemost 86 (2001) 189-197
155. Deckmyn H., van Houtte E., and Vermylen J. Disturbed platelet aggregation to collagen associated with an antibody against an 85-to 90-kD platelet glycoprotein in a patient with prolonged bleeding time. Blood 79 (1992) 1466-1471
156. Moog S., Mangin P., Lenain N., Strassel C., Ravanat C., Schuhler S., et al. Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood 98 (2001) 1038-1046
157. Ikeda H. Platelet membrane protein CD36. Hokkaido Igaku Zasshi 74 (1999) 99-104
158. Yamamoto N., Akamatsu N., Yamazaki H., and Tanoue K. Normal aggregation of glycoprotein IV (CD36)-deficient platelets from seven healthy Japanese donors. Br J Haematol 81 (1992) 86-92
159. Tandon N.N., Ockenhouse C.F., Greco N.J., and Jamieson G.A. Adhesive functions of platelets lacking glycoprotein IV (CD36). Blood 78 (1991) 2809-2813
160. Kehrel B., Kronenberg A., Rauterberg J., Niesing-Bresch D., Niehues U., Kardoeus J., et al. Platelets deficient in glycoprotein IIIb aggregate normally to collagens type I and III but not to collagen type V. Blood 82 (1993) 3364-3370
161. Volf I., Moeslinger T., Cooper J., Schmid W., and Koller E. Human platelets exclusively bind oxidized low density lipoprotein showing no specificity for acetylated low density lipoprotein. FEBS Lett 449 (1999) 141-145
162. Chiang T.M., Seyer J.M., and Kang A.H. Collagen platelet interaction: separate receptor sites for types I and III collagen. Thromb Res 71 (1993) 443-456
163. Monnet E., and Fauvel-Lafeve F. A new platelet receptor specific to type III collagen: type III collagen-binding protein. J Biol Chem 275 (2000) 10912-10917
164. Liu C.Z., Wang Y.C., Wang J.H., Shaw C.K., and Lin G.L. Differential expression of platelet glycoprotein Ia/IIa in Taiwan Chinese corresponds to glycoprotein Ia gene polymorphisms. J Pharmacol Sci 101 (2006) 103-106
165. Maakaroun A., Regina S., Delahousse B., Saudeau D., and Gruel Y. Ischaemic strokes and homozygosity for the [alpha]2 807T allele of the platelet collagen receptor in young monozygotic twins. Blood Coagul Fibrinolysis 14 (2003) 83-85
166. Kunicki T.J., and Nugent D.J. The influence of platelet glycoprotein polymorphisms on receptor function and risk for thrombosis. Vox Sang 83 (2002) 85-90
167. 2 gene coding sequence. Blood 89 (1997) 1939-1943
168. Dodson P.M., Haynes J., Starczynski J., Farmer J., Shigdar S., Fegan G., et al. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion. Eye 17 (2003) 772-777
169. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E., Ramirez C., Cavallari U., Trabetti E., et al. Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene. Am J Cardiol 96 (2005) 1095-1099
170. Tsantes A.E., Nikolopoulos G.K., Bagos P.G., Vaiopoulos G., and Travlou A. Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and coronary artery disease: a meta-analysis. Int J Cardiol 118 (2007) 189-196
171. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E., Ramirez C., Escaned J., Moreno R., et al. 807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment. Blood Coagul Fibrinolysis 15 (2004) 427-433
172. Zhao Y., Wang Y., and Zhu J. Correlation between the polymorphism of glycoprotein Ia gene and acute coronary syndrome. Chin Med Sci J 19 (2004) 13-18
173. Cole V.J., Staton J.M., Eikelboom J.W., Hankey G.J., Yi Q., Shen Y., et al. Collagen platelet receptor polymorphisms integrin alpha2beta1 C807T and GPVI Q317L and risk of ischemic stroke. J Thromb Haemost 1 (2003) 963-970
174. Furihata K., Clemetson K.J., Deguchi H., and Kunicki T.J. Variation in human platelet glycoprotein VI content modulates glycoprotein VI-specific prothrombinase activity. Arterioscler Thromb Vasc Biol 21 (2001) 1857-1863
175. Jandrot-Perrus M., Busfield S., Lagrue A.H., Xiong X., Debili N., Chickering T., et al. Cloning, characterization, and functional studies of human and mouse glycoprotein VI. a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood 96 (2000) 1798-1807
176. Berlanga O., Tulasne D., Bori T., Snell D.C., Miura Y., Jung S., et al. The Fc receptor gamma-chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C-type lectin, convulxin. Eur J Biochem 269 (2002) 2951-2960
177. Croft S.A., Samani N.J., Teare M.D., Hampton K.K., Steeds R.P., Channer K.S., et al. Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation 104 (2001) 1459-1463
178. Lepantalo A., Mikkelsson J., Resendiz J.C., Viiri L., Backman J.T., Kankuri E., et al. Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients. Thromb Haemost 95 (2006) 253-259
179. Ollikainen E., Mikkelsson J., Perola M., Penttila A., and Karhunen P.J. Platelet membrane collagen receptor glycoprotein VI polymorphism is associated with coronary thrombosis and fatal myocardial infarction in middle-aged men. Atherosclerosis 176 (2004) 95-99
180. De Meyer S.F., Vanhoorelbeke K., Ulrichts H., Staelens S., Feys H.B., Salles I., et al. Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs. Cardiovasc Hematol Disord Drug Targets 6 (2006) 191-207
181. Deckmyn H., Cauwenberghs N., Wu D., Depraetere H., and Vanhoorelbeke K. Development of antibodies that interfere with the collagen-VWF-GPIb axis as new antithrombotics. Verh K Acad Geneeskd Belg 67 (2005) 55-65
182. Schulte V., Reusch H.P., Pozgajova M., Varga-Szabo D., Gachet C., and Nieswandt B. Two-phase antithrombotic protection after anti-glycoprotein VI treatment in mice. Arterioscler Thromb Vasc Biol 26 (2006) 1640-1647
183. Cauwenberghs N., Vanhoorelbeke K., Vauterin S., Westra D.F., Romo G., Huizinga E.G., et al. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibα reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ib alpha. Blood 98 (2001) 652-660
184. Coller B.S., Beer J.H., Scudder L.E., and Steinberg M.H. Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood 74 (1989) 182-189
185. Chu X., Hou M., Peng J., Zhu Y., Zhang F., Ji X., et al. Identification of human platelet glycoprotein VI-specific IgG autoantibody and its fragments. Blood Coagul Fibrinolysis 17 (2006) 403-407
186. 1 integrin. Thromb Res 105 (2002) 153-160
187. Luzak B., Golanski J., Rozalski M., Bonclerand M.A., and Watala C. Inhibition of collagen-induced platelet reactivity by DGEA peptide. Acta Biochim Pol 50 (2003) 1119-1128
188. Maurice P., Pires V., Amant C., Kauskot A., Da Nascimento S., Sonnet P., Rochette J., Legrand C., Fauvel-Lafeve F., and Bonnefoy A. Antithrombotic effect of the type III collagen-related octapeptide (KOGEOGPK) in the mouse. Vascul Pharmacol 44 (2006) 42-49
189. Zhu J., Cole F., Woo-Rasberry V., Fang X.R., and Chiang T.M. Type I and type III collagen-platelet interaction: inhibition by type specific receptor peptides. Thromb Res 119 (2007) 111-119
190. Myers Jr. D.D., Henke P.K., Bedard P.W., Wrobleski S.K., Kaila N., Shaw G., et al. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg 44 (2006) 625-632
191. Lasser G., Guchhait P., Ellsworth J.L., Sheppard P., Lewis K., Bishop P., et al. C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen. Blood 107 (2006) 423-430
192. Hubbard G.P., Wolffram S., Lovegrove J.A., and Gibbins J.M. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2 (2004) 2138-2145
193. Hubbard G.P., Wolffram S., de Vos R., Bovy A., Gibbins J.M., and Lovegrove J.A. Ingestion of onion soup high in quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in man: a pilot study. Br J Nutr 96 (2006) 482-488
194. Francischetti I.M., Saliou B., Leduc M., Carlini C.R., Hatmi M., Randon J., et al. Convulxin, a potent platelet-aggregating protein from Crotalus durissus terrificus venom, specifically binds to platelets. Toxicon 35 (1997) 1217-1228
195. Du X.Y., Clemetson J.M., Navdaev A., Magnenat E.M., Wells T.N., and Clemetson K.J. Ophioluxin, a convulxin-like C-type lectin from Ophiophagus hannah (King cobra) is a powerful platelet activator via glycoprotein VI. J Biol Chem 277 (2002) 35124-35132
196. Andrews R.K., Gardiner E.E., Shen Y., and Berndt M.C. Structure-activity relationships of snake toxins targeting platelet receptors, glycoprotein Ib-IX-V and glycoprotein VI. Curr Med Chem Cardiovasc Hematol Agents 1 (2003) 143-149
197. Andrews R.K., Gardiner E.E., Asazuma N., Berlanga O., Tulasne D., Nieswandt B., et al. A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI. J Biol Chem 276 (2001) 28092-28097
198. Crosby D., and Poole A.W. Physical and functional interaction between protein kinase C delta and Fyn tyrosine kinase in human platelets. J Biol Chem 278 (2003) 24533-24541
199. 1 and GPIb in a phosphatidylinositol 3-kinase independent pathway. Biochem Biophys Res Commun 285 (2001) 689-695
200. Navdaev A., Clemetson J.M., Polgar J., Kehrel B.E., Glauner M., Magnenat E., et al. Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (Malayan pit viper), stimulates platelets by binding to alpha 2beta 1 integrin and glycoprotein Ib, activating Syk and phospholipase C gamma 2, but does not involve the glycoprotein VI/Fc receptor gamma chain collagen receptor. J Biol Chem 276 (2001) 20882-20889
201. Huang T.F., Liu C.Z., and Yang S.H. Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist. Biochem J 309 (1995) 1021-1027
202. 1 integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Ibα. J Biol Chem 276 (2001) 25121-25126
203. Liu C.Z., and Huang T.F. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction. Arch Biochem Biophys 337 (1997) 291-299
204. Zhou Q., Dangelmaier C., and Smith J.B. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain. Biochem Biophys Res Commun 219 (1996) 720-726
205. Serrano S.M., Wang D., Shannon J.D., Pinto A.F., Polanowska-Grabowska R.K., and Fox J.W. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation. FEBS J 274 (2007) 3611-3621
206. Hers I., Berlanga O., Tiekstra M.J., Kamiguti A.S., Theakston R.D., and Watson S.P. Evidence against a direct role of the integrin alpha2beta1 in collagen-induced tyrosine phosphorylation in human platelets. Eur J Biochem 267 (2000) 2088-2097
207. Xu G., Ulrichts H., Vauterin S., De Meyer S.F., Deckmyn H., Teng M., et al. How does agkicetin-C bind on platelet glycoprotein Ibα and achieve its platelet effects?. Toxicon 45 (2005) 561-570
208. Wang W.J., Shih C.H., and Huang T.F. Primary structure and antiplatelet mechanism of a snake venom metalloproteinase, acurhagin, from Agkistrodon acutus venom. Biochimie 87 (2005) 1065-1077
209. Teng C.M., Lin C.H., Lin C.N., Chung M.I., and Huang T.F. Frangulin B, an antagonist of collagen-induced platelet aggregation and adhesion, isolated from Rhamnus formosana. Thromb Haemost 70 (1993) 1014-1018
210. Molina V., Carbajal D., Arruzazabala L., and Mas R. Effect of D-003 on intravascular platelet aggregation induced with collagen in rats. J Med Food 8 (2005) 232-236
211. Hsiao G., Lee J.J., Lin K.H., Shen C.H., Fong T.H., Chou D.S., et al. Characterization of a novel and potent collagen antagonist, caffeic acid phenethyl ester, in human platelets: in vitro and in vivo studies. Cardiovasc Res 75 (2007) 782-792